HWLAX
Price
$47.13
Change
+$0.69 (+1.49%)
Updated
Dec 3 closing price
Net Assets
360.19M
VVIAX
Price
$74.33
Change
+$0.66 (+0.90%)
Updated
Dec 3 closing price
Net Assets
207.95B
Interact to see
Advertisement

HWLAX vs VVIAX

Header iconHWLAX vs VVIAX Comparison
Open Charts HWLAX vs VVIAXBanner chart's image
Hotchkis & Wiley Large Cap Fdml Value A
Price$47.13
Change+$0.69 (+1.49%)
VolumeN/A
Net Assets360.19M
Vanguard Value Index Adm
Price$74.33
Change+$0.66 (+0.90%)
VolumeN/A
Net Assets207.95B
HWLAX vs VVIAX Comparison Chart in %
View a ticker or compare two or three
VS
HWLAX vs. VVIAX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HWLAX is a Buy and VVIAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 208B vs. HWLAX (360M). VVIAX pays higher dividends than HWLAX: VVIAX (2.04) vs HWLAX (1.17). HWLAX was incepted earlier than VVIAX: HWLAX (24 years) vs VVIAX (25 years). HWLAX (1.18) is less costly to investors than VVIAX (0.05). HWLAX is a more actively managed with annual turnover of: 40.00 vs. VVIAX (9.00). HWLAX has a lower initial minimum investment than VVIAX: HWLAX (2500) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 6.10 vs. HWLAX (-0.32). VVIAX return over 5 years is better than : 60.40 vs. HWLAX (41.14).
HWLAXVVIAXHWLAX / VVIAX
Total Expense Ratio1.180.052,360%
Annual Report Gross Expense Ratio1.180.052,360%
Fund Existence24 years25 years-
Gain YTD14.89512.640118%
Front Load5%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets360M208B0%
Annual Yield % from dividends1.172.0458%
Returns for 1 year-0.326.10-5%
Returns for 3 years10.5230.8234%
Returns for 5 years41.1460.4068%
Returns for 10 years102.49128.9080%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALLO1.520.18
+13.43%
Allogene Therapeutics
BCAB0.830.05
+6.00%
BioAtla
AGIO27.490.51
+1.89%
Agios Pharmaceuticals
WTGUU10.30N/A
N/A
Wintergreen Acquisition Corp.
UGI37.64-0.49
-1.29%
UGI Corp